BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 21185364)

  • 1. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
    Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J
    Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target-specific cellular uptake of taxol-loaded heparin-PEG-folate nanoparticles.
    Wang Y; Wang Y; Xiang J; Yao K
    Biomacromolecules; 2010 Dec; 11(12):3531-8. PubMed ID: 21086982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
    Chen J; Li S; Shen Q; He H; Zhang Y
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological activity of DTPA linked to protein-based drug carrier systems.
    Michaelis M; Langer K; Arnold S; Doerr HW; Kreuter J; Cinatl J
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1236-40. PubMed ID: 15451429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells.
    Zhang L; Hou S; Mao S; Wei D; Song X; Lu Y
    Int J Pharm; 2004 Dec; 287(1-2):155-62. PubMed ID: 15541922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery.
    Zhang HZ; Li XM; Gao FP; Liu LR; Zhou ZM; Zhang QQ
    Drug Deliv; 2010 Jan; 17(1):48-57. PubMed ID: 22747075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
    Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B
    Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
    Zheng Y; Cai Z; Song X; Chen Q; Bi Y; Li Y; Hou S
    J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, pharmacoscintigraphic evaluation and antitumor efficacy of methotrexate-loaded, folate-conjugated, stealth albumin nanoparticles.
    Jain S; Mathur R; Das M; Swarnakar NK; Mishra AK
    Nanomedicine (Lond); 2011 Dec; 6(10):1733-54. PubMed ID: 22087800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
    Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
    Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid-functionalized human serum albumin nanocapsules for targeted drug delivery to chronically activated macrophages.
    Rollett A; Reiter T; Nogueira P; Cardinale M; Loureiro A; Gomes A; Cavaco-Paulo A; Moreira A; Carmo AM; Guebitz GM
    Int J Pharm; 2012 May; 427(2):460-6. PubMed ID: 22374516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles.
    Zhang LK; Hou SX; Zhang JQ; Hu WJ; Wang CY
    Arch Pharm Res; 2010 Aug; 33(8):1193-8. PubMed ID: 20803122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trastuzumab decorated methotrexate-human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells.
    Taheri A; Dinarvand R; Atyabi F; Ghahremani MH; Ostad SN
    Eur J Pharm Sci; 2012 Sep; 47(2):331-40. PubMed ID: 22771547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles.
    Akbarian A; Ebtekar M; Pakravan N; Hassan ZM
    Int J Biol Macromol; 2020 Jun; 152():90-101. PubMed ID: 32057865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles.
    Teow Y; Valiyaveettil S
    Nanoscale; 2010 Dec; 2(12):2607-13. PubMed ID: 20936240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types.
    Bae S; Ma K; Kim TH; Lee ES; Oh KT; Park ES; Lee KC; Youn YS
    Biomaterials; 2012 Feb; 33(5):1536-46. PubMed ID: 22118776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.